iRay Technology Company Limited

XSSC:688301 Stock Report

Market Cap: CN¥16.4b

iRay Technology Valuation

Is 688301 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688301 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688301 (CN¥114.87) is trading below our estimate of fair value (CN¥1440.97)

Significantly Below Fair Value: 688301 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688301?

Key metric: As 688301 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688301. This is calculated by dividing 688301's market cap by their current earnings.
What is 688301's PE Ratio?
PE Ratio29x
EarningsCN¥564.72m
Market CapCN¥16.38b

Price to Earnings Ratio vs Peers

How does 688301's PE Ratio compare to its peers?

The above table shows the PE ratio for 688301 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average86.4x
688198 Beijing Balance Medical TechnologyLtd
155.3x41.1%CN¥16.1b
300633 SonoScape Medical
62.9x54.7%CN¥15.3b
300298 Sinocare
62.5x34.9%CN¥13.8b
600055 Beijing Wandong Medical TechnologyLtd
64.8xn/aCN¥11.9b
688301 iRay Technology
29x30.9%CN¥16.4b

Price-To-Earnings vs Peers: 688301 is good value based on its Price-To-Earnings Ratio (29x) compared to the peer average (86.4x).

Price to Earnings Ratio vs Industry

How does 688301's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
688301 29.0xIndustry Avg. 36.1xNo. of Companies16PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 688301 is good value based on its Price-To-Earnings Ratio (29x) compared to the CN Medical Equipment industry average (35.5x).

Price to Earnings Ratio vs Fair Ratio

What is 688301's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688301 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29x
Fair PE Ratio37.3x

Price-To-Earnings vs Fair Ratio: 688301 is good value based on its Price-To-Earnings Ratio (29x) compared to the estimated Fair Price-To-Earnings Ratio (37.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 688301 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥114.87
CN¥181.51
+58.0%
23.3%CN¥252.86CN¥138.78n/a6
Nov ’25CN¥116.75
CN¥181.51
+55.5%
23.3%CN¥252.86CN¥138.78n/a6
Oct ’25CN¥126.84
CN¥194.35
+53.2%
23.6%CN¥252.86CN¥136.45n/a6
Sep ’25CN¥91.94
CN¥194.35
+111.4%
23.6%CN¥252.86CN¥136.45n/a6
Aug ’25CN¥104.60
CN¥202.44
+93.5%
18.5%CN¥252.86CN¥149.73n/a6
Jul ’25CN¥112.37
CN¥206.74
+84.0%
15.6%CN¥252.86CN¥175.49n/a6
Jun ’25CN¥121.61
CN¥206.74
+70.0%
15.6%CN¥252.86CN¥175.49n/a6
May ’25CN¥141.94
CN¥212.57
+49.8%
13.7%CN¥252.86CN¥175.49n/a6
Apr ’25CN¥160.49
CN¥220.23
+37.2%
9.2%CN¥252.86CN¥193.57n/a6
Mar ’25CN¥169.49
CN¥219.93
+29.8%
10.1%CN¥252.86CN¥193.57n/a5
Feb ’25CN¥153.58
CN¥219.93
+43.2%
10.1%CN¥252.86CN¥193.57n/a5
Jan ’25CN¥232.33
CN¥213.64
-8.0%
7.2%CN¥238.36CN¥193.57n/a5
Dec ’24CN¥153.14
CN¥214.38
+40.0%
8.0%CN¥238.36CN¥193.57n/a4
Nov ’24CN¥158.59
CN¥214.38
+35.2%
8.0%CN¥238.36CN¥193.57CN¥116.754
Oct ’24CN¥175.04
CN¥236.38
+35.0%
5.9%CN¥255.04CN¥209.29CN¥126.846
Sep ’24CN¥172.92
CN¥243.42
+40.8%
8.9%CN¥280.61CN¥209.29CN¥91.946
Aug ’24CN¥187.64
CN¥257.13
+37.0%
7.9%CN¥281.14CN¥232.14CN¥104.607
Jul ’24CN¥201.74
CN¥257.13
+27.5%
7.9%CN¥281.14CN¥232.14CN¥112.377
Jun ’24CN¥212.36
CN¥257.13
+21.1%
7.9%CN¥281.14CN¥232.14CN¥121.617
May ’24CN¥196.79
CN¥267.70
+36.0%
8.8%CN¥306.12CN¥238.54CN¥141.947
Apr ’24CN¥184.61
CN¥267.71
+45.0%
8.8%CN¥306.12CN¥238.54CN¥160.497
Mar ’24CN¥206.47
CN¥281.72
+36.4%
8.0%CN¥311.22CN¥244.39CN¥169.496
Feb ’24CN¥233.55
CN¥289.80
+24.1%
5.9%CN¥311.22CN¥269.15CN¥153.585
Jan ’24CN¥233.61
CN¥296.52
+26.9%
6.5%CN¥311.22CN¥269.15CN¥232.333
Dec ’23CN¥237.97
CN¥296.52
+24.6%
6.5%CN¥311.22CN¥269.15CN¥153.143
Nov ’23CN¥257.99
CN¥276.91
+7.3%
17.0%CN¥311.22CN¥210.31CN¥158.593

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.65

7D

-4.6%

1Y

-27.1%

Truking Technology

CN¥4.6b

Engages in medical equipment business in China and internationally.

300358

CN¥7.76

7D

-3.8%

1Y

-35.3%

iRay Technology

CN¥16.4b

Develops, manufactures, and sells flat panel X-ray detectors for use in medical, dental, oncology, veterinary, security, and industrial imaging applications in China and internationally.

688301

CN¥114.87

7D

-10.7%

1Y

-32.1%